Stock & Company Details
BioNexus Gene Lab Corp $BGLC
Price:
N/A
N/A
2.9M
$3.1M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.67
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
BGLC technical indicators
Latest BioNexus Gene Lab Corp (BGLC) indicator readings as of 2026-10-29.
BGLC's 14-day RSI is 27.2, in oversold territory. At $0.98 it is trading 51.2% below its 200-day moving average of $2.01, and below its 50-day average of $1.37. Price sits below the lower Bollinger Band ($1.04 to $1.40). ADX reads 12.1, indicating a range-bound market rather than a trend.
Overview
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.
Finance Bot
Ask your questions
Start by typing a question below.
